Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
about
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersDepression as a Glial-Based Synaptic DysfunctionGlia in the cytokine-mediated onset of depression: fine tuning the immune responseAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueGlial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?The stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionA putative functional role for oligodendrocytes in mood regulationRegulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completersAltered functional protein networks in the prefrontal cortex and amygdala of victims of suicideFluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes.Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state.Acute cocaine exposure elicits rises in calcium in arousal-related laterodorsal tegmental neuronsInvolvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed miceBiological substrates underpinning diagnosis of major depression.NDRG2 as a marker protein for brain astrocytes.Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression.Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings.Markers of apoptosis induction and proliferation in the orbitofrontal cortex in alcohol dependence.Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorderSix-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.Astrocytic hypertrophy in anterior cingulate white matter of depressed suicidesReduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorderChronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus.Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorderGABAergic control of depression-related brain statesPeripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex.Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorderA pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder.Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disordersKetamine as antidepressant? Current state and future perspectives.Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug AbuseGlutamine Synthetase: Role in Neurological Disorders.The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.Gender-Related Hippocampal Proteomics Study from Young Rats After Chronic Unpredicted Mild Stress Exposure.Human astrocytes in the diseased brain.
P2860
Q24632936-A3A6BB1E-8EC2-4945-BFE0-6BF3A37F5994Q26772830-AAC533DB-ACD9-4F51-B389-40A6EA80FBC5Q26798929-4618A5BC-79E0-4443-9108-40E9325CB5C9Q26827833-0A64EB58-59A6-4C69-8A4C-4D4787C17095Q26829556-D4CED51D-8448-48D8-A9F4-5937529B5A60Q26859198-CD45EF19-157A-4911-99BE-6960C7D8B8B2Q26995174-7BD95E47-F631-48EC-9B83-4C92F11AFA6DQ28385646-AF77DF4B-2F58-410D-927F-7F0D6DE7CA23Q28485508-EF27A67D-117B-4014-ABD4-9232FCA79E71Q30474244-180BA5B0-C6C2-4DF2-863C-7D756F9EF35FQ30572014-028F89E1-059A-419A-9150-CBCE4BCE7233Q30848010-D85DDC7F-402C-4866-96C6-804694862F2FQ33771394-23E74065-BA11-4647-9A8E-6D18ECDE9A15Q33814381-221DA146-D82F-4C63-AA1D-A4FC4A9FA0F4Q33820463-66DA8440-8321-4D36-AB6F-BE966C01A8EAQ33829143-F57BE765-4E0C-450C-9A8C-BACE35206388Q33834681-E6EA2B19-9A99-4DB3-9EA6-2113AE45DD19Q33874356-8A949427-1F9C-43BD-BB51-1FD7229C5D89Q34216839-0042339B-A32C-432E-A3AA-0CEFA1E72F65Q34573986-0C07BA9C-B90C-4BFF-9389-55E6734FE4CDQ34588846-3A881588-919F-4243-B222-48A3D8EF14F5Q34773574-3D2C60E9-6536-4B26-A5EA-547CB919E726Q35592026-717FC203-B787-46AA-BF6A-C5D49D8306D5Q35933481-20FD0879-04C6-4939-B9B0-17488CF1C54BQ36301537-1B8B1076-5E32-4940-84D3-DB302A0D3E3EQ36625760-9F00F5DC-3ED0-4919-88FA-5EBE5127A9AEQ36668325-74629085-113D-44D6-9695-61F94D03CDD7Q36808636-6097FB03-75E6-491C-9CA7-5AA7F1AD5CC0Q36812629-D9C3B66D-6652-46D1-844C-C1985084861CQ36813144-20752B75-9864-43DF-B8F1-B3343F8A0D38Q36852624-B0BA16A4-1A03-4151-AEEF-E8447D0DD5D2Q36915565-9AA9C713-2AC0-44B6-A7CA-6EAE7FA5C64EQ36944201-FB3711DD-D2B4-40F7-87DC-8B2DE041D97CQ37559823-EE47FCC6-5677-4B8F-B9B1-0701B5D10B2FQ38512084-F794AE1E-D7A3-4DAE-9B16-F3BA0D9E7209Q38729846-35D0C4A0-81FB-4692-95B0-CF7D691A681AQ39019322-1AD1B04C-EBEA-46C3-8107-A7059007D9B3Q39029383-CC2FA36B-66EB-4928-9DCC-0D11BFB38115Q39033806-E6E12E9F-5039-442A-9F52-5FF9AC338578Q39141123-8487E02D-D166-4C10-B6FA-A30402653B3D
P2860
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@ast
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@en
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@nl
type
label
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@ast
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@en
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@nl
prefLabel
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@ast
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@en
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@nl
P2093
P2860
P1476
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
@en
P2093
Angela A Whittom
Craig A Stockmeier
Grazyna Rajkowska
Mark C Austin
Robert Waltzer
P2860
P304
P356
10.1016/J.JAD.2010.06.003
P577
2010-06-26T00:00:00Z